Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rise in prevalence of gastric ulcer
3.2.1.2 Increasing geriatric population at risk
3.2.1.3 Growing demand for point-of-care testing devices
3.2.1.4 Rising adoption of non-invasive H. pylori testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of skilled professionals for invasive testing
3.2.2.2 Lack of awareness regarding H. pylori infection
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technology landscape
3.7 Pricing analysis
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Gap analysis
3.11 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Invasive
5.2.1 Histology
5.2.2 Rapid urease test
5.2.3 HP culture
5.3 Non-invasive
5.3.1 Serologic test
5.3.2 Urea breath test
5.3.3 Stool/fecal antigen test
Chapter 6 Market Estimates and Forecast, By Method, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Point of care (POC) tests
6.3 Laboratory based tests
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Diagnostic laboratories
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Advance Pharma
9.3 Avanos Corporate
9.4 Biohit Oyj
9.5 bioMerieux SA
9.6 Bio-Rad Laboratories, Inc.
9.7 Cardinal Health, Inc.
9.8 Epitope Diagnostics
9.9 Gulf Coast Scientific
9.10 Laboratory Corporation of America, Inc.
9.11 Medline Industries
9.12 Meridian Biosciences, Inc.
9.13 Quidel Corporation
9.14 TECHLAB, Inc
9.15 Thermo Fischer Scientific Corporation
